JPX : 4534.T

Mochida Pharmaceutical Co., Ltd.

$3180 JPY

$60 (1.92%)

Volume
143.9K
Average Volume
67.08K
Market Capitalization
$112.42B
P/E Ratio
14.26
Dividend Yield
2.52%
Price Target
Year High
$3965.00
Year Low
$2929.00
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$4.29
Company Overview

JPX

Naoyuki Mochida

Drug Manufacturers - Specialty & Generic

Healthcare

4534.T

1479

JP

JPY

https://www.mochida.co.jp

81 3 3358 7211

N/A

N/A

Liquidity Metrics

0.07

4.29

2.99

1.01

0.00

Sales & Valuation

$116.95B

0.96

0.80

0.00

0.00

Profitability

$222.93

$7.9B

6.76%

9.55%

5.81%

4.33%

P/E Metrics

14.26

0.37

0.37

Analyst Price Target & Rating

Neutral

3/5

0 Analysts

%

Financial Health Scores

3.91

4/9

$91.29B

$182.72B

$42.39B

$10.15B

Key Metrics (TTM)

No key metrics data available.

Company Executives
Name Title
Yoshitaka Hosaka Executive Managing Officer & Head of Business Promotion Headquarters
Junichi Sakaki Senior Executive Managing Officer & Representative Director
Tomokazu Matsusue Managing Executive Officer & Head of Business Development Division
Hitoshi Mizuno Managing Executive Officer & GM of Medical Device Product Development
Junichi Makino Executive Officer Deputy Head of Pharmaceutical Sales Division
Masaaki Yokosuka Executive Officer and Legal & Compliance Manager
Taiji Hayano GM of Pharmaceutical Development Division & Managing Executive Officer
Kenji Miyajima Director & Managing Executive Officer
Yutaka Kawakami Managing Executive Officer & Executive Director
Motoi Mitsuishi Senior Executive Managing Officer & Representative Director
Naoyuki Mochida President & Chairperson
Poll Results

No votes yet today — be the first to share your view!

About Mochida Pharmaceutical Co., Ltd. (JPX:4534.T) Stock

Established in 1913 and headquartered in Tokyo, Japan, Mochida Pharmaceutical Co., Ltd. specializes in the development, manufacturing, and distribution of a wide array of medical and personal care products. Its primary offerings encompass pharmaceuticals, diagnostic solutions, and skincare lines. The company's extensive pharmaceutical portfolio includes treatments for a variety of conditions, such as cardiovascular issues, pain (analgesics), gastrointestinal ailments, neurological disorders, infections (anti-infectives), diabetes (antidiabetics), and cancer (oncological agents). Additionally, it provides hormone and biological preparations, alongside biosimilars, catering to therapeutic areas like dermatology, psychiatry, obstetrics, and gynecology. In diagnostics, Mochida produces various ... reagents, particularly those utilized for fertility and infertility assessments. Its skincare division features products designed for facial, body, and hair care. Beyond its existing product range, Mochida Pharmaceutical actively invests in research and development, with a specific focus on creating therapies for intractable diseases. The company has also forged strategic collaborations, including a partnership with Amarin Corporation plc for the advancement and market introduction of ethyl icosapentate products. Furthermore, it collaborates with Gene Techno Science Co., Ltd. to innovate regenerative medicine targeting rare and challenging digestive disorders, such as congenital isolated hypoganglionosis.

Frequently Asked Questions

What is the current Mochida Pharmaceutical Co., Ltd. (4534.T) stock price?

Mochida Pharmaceutical Co., Ltd.(JPX:4534.T) stock price is $3180 in the last trading session. During the trading session, 4534.T stock reached the peak price of $3965 while $2929 was the lowest point it dropped to. The percentage change in 4534.T stock occurred in the recent session was 1.92% while the dollar amount for the price change in 4534.T stock was $60.

4534.T's industry and sector of operation?

The JPX listed 4534.T is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.

Who are the executives of 4534.T?

Yoshitaka Hosaka | Executive Managing Officer & Head of Business Promotion Headquarters
Junichi Sakaki | Senior Executive Managing Officer & Representative Director
Tomokazu Matsusue | Managing Executive Officer & Head of Business Development Division
Hitoshi Mizuno | Managing Executive Officer & GM of Medical Device Product Development
Junichi Makino | Executive Officer Deputy Head of Pharmaceutical Sales Division

How many employees does 4534.T have?

Number of 4534.T employees currently stands at 1479. 4534.T operates from 7, Yotsuya 1-chome, Tokyo, TY 162-0845, JP.

Link for 4534.T official website?

Official Website of 4534.T is: https://www.mochida.co.jp

How do I contact 4534.T?

4534.T could be contacted at phone #81 3 3358 7211 and can also be accessed through its website. 4534.T operates from 7, Yotsuya 1-chome, Tokyo, TY 162-0845, JP.

How many shares of 4534.T are traded daily?

The average number of 4534.T shares traded daily for last 3 months was 67.08K.

What is the market cap of 4534.T currently?

The market value of 4534.T currently stands at $112.42B with its latest stock price at $3180